Page 2 - Simba Gill News Today

The rise of British biotech—part of late ’70s and early ’80s culture—should be better documented and made part of our shared history.

CAMBRIDGE, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new...

Published: Jun 01, 2021 CAMBRIDGE, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointment of Mark Plinio as Chief Commercial Officer, effective June 14, 2021. Mr. Plinio brings significant pharmaceutical sales and marketing leadership to Evelo, including experience building and managing blockbuster brands through all stages of commercializ...

Evelo Biosciences Announces Appointment of Mark Plinio as Chief Commercial Officer June 01, 2021 07:00 ET | Source: Evelo Biosciences, Inc. Evelo Biosciences, Inc. Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointment of Mark Plinio as Chief Commer...

Evelo Biosciences, Inc.: Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights -Presented further positive data from Phase 1b clinical trial of EDP1815 at International Society of Atopic Dermatitis Meeting- -Strengthened leadership team with appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to Board of Directors- -Announced strategic collaboration with Abdul Latif Jameel Health to develop and commercialize EDP1815 in select developing mar...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights Evelo Biosciences, Inc.April 29, 2021 GMT –Presented further positive data from Phase 1b clinical trial of EDP1815 at International Society of Atopic Dermatitis Meeting– –Strengthened leadership team with appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to Board of Directors– –...

Evelo Biosciences, Inc. (EVLO) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Evelo Biosciences, Inc. (NASDAQ: EVLO) Q1 2021 Earnings Call Good morning, and welcome to Evelo Biosciences conference call to discuss the first-quarter 2021 financial results and business highlights. [Operator instructions] Please be advised that this call is being recorded at the companys request. At this time, Id like to turn ...

(0) CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointments of Luca Scavo as Chief Financial Officer (CFO), effective June 1, 2021, and Julie H. McHugh to its Board of Directors, effective immediately. Mr. Scavo brings more than 25 years of international experience in both emerging and developed markets within pioneering biotechnolo...

Published: Mar 09, 2021 –Announced new positive data in human experimental model of inflammation of EDP1815– –Completed enrollment in Phase 2b dose-ranging trial for EDP1815 in psoriasis; full data set accelerated and now expected in 3Q 2021– –Initiated Phase 1b clinical trial of EDP1867 in atopic dermatitis; data expected in 4Q 2021– –Up to 8 clinical data readouts expected over next 18 months– –Management to host conference call at 8:30 a.m. ET– CAMBRIDGE, Mass., March...

(2) -Announced new positive data in human experimental model of inflammation of EDP1815- -Completed enrollment in Phase 2b dose-ranging trial for EDP1815 in psoriasis; full data set accelerated and now expected in 3Q 2021- -Initiated Phase 1b clinical trial of EDP1867 in atopic dermatitis; data expected in 4Q 2021- -Up to 8 clinical data readouts expected over next 18 months- -Management to host conference call at 8:30 a.m. ET- CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) -- Evelo Biosci...